Lv41
450 积分 2023-01-07 加入
Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects
1年前
已完结
Aging-disturbed FUS phase transition impairs hematopoietic stem cells by altering chromatin structure
1年前
已关闭
CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant
1年前
已完结
Polycystic ovary syndrome
2年前
已完结
Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myeloma
2年前
已完结
Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus
2年前
已完结
Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential
2年前
已完结
The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer
2年前
已完结
LTK fusions: A new target emerges in non-small cell lung cancer
2年前
已完结
皖公网安备34019202002308
